Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

被引：0
|
作者：
Philip Q. Bao
Ramesh K. Ramanathan
Alyssa Krasinkas
Nathan Bahary
Barry C. Lembersky
David L. Bartlett
Steven J. Hughes
Kenneth K. Lee
A. James Moser
Herbert J. Zeh
机构：
[1] Stony Brook University Hospital,Department of Surgery
[2] Virginia G. Piper Cancer Center,Department of Pathology
[3] University of Pittsburgh Medical Center,Department of Medical Oncology
[4] University of Pittsburgh Medical Center,Department of Surgery, Division of Surgical Oncology
[5] University of Pittsburgh Medical Center,undefined
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：323 / 323
相关论文
共 50 条
  • [21] A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
    Ueno, H.
    Kosuge, T.
    Matsuyama, Y.
    Yamamoto, J.
    Nakao, A.
    Egawa, S.
    Doi, R.
    Monden, M.
    Hatori, T.
    Tanaka, M.
    Shimada, M.
    Kanemitsu, K.
    BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 908 - 915
  • [22] A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.
    Han, Boram
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoungyong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Kim, Jung Hoon
    Song, Hunho
    Park, Choong Kee
    Moon, Sung Hoon
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Lee, Jung Woo
    Zang, Dae Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [23] A phase I study of erlotinib, bevacizumab and gemcitabine in patients with advanced pancreatic cancer
    Gomez-Martin, C.
    Camara, J. C.
    Cortes, H.
    Jara, C.
    Gravalos, C.
    Rubio, B.
    Amador, M. L.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] A phase II study of gemcitabine plus carboplatin as adjuvant chemotherapy in patients with resected NSCLC
    Yoshino, Reiko
    Tomizawa, Yoshio
    Takei, Kousuke
    Tomizawa, Mai
    Yoshii, Akihiro
    Kawashima, Osamu
    Watanabe, Satoru
    Hisada, Takeshi
    Saitou, Ryusei
    Yamada, Masanobu
    ANNALS OF ONCOLOGY, 2015, 26 : 98 - 98
  • [25] Gemcitabine/taxane adjuvant therapy in resected pancreatic cancer: A signal of improved survival?
    Kanji, Zaheer S.
    Edwards, Alicia M.
    Mandelson, Margaret T.
    Lin, Bruce
    Badiozamani, Kasra
    Song, Goubin
    Alseidi, Adnan
    Biehl, Thomas
    Kozarek, Richard A.
    Helton, William Scott
    Picozzi, Vincent J.
    Rocha, Flavio G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [26] Completion of adjuvant therapy in patients with resected pancreatic cancer
    DePeralta, Danielle K.
    Ogami, Takuya
    Zhou, Jun-Min
    Schell, Michael J.
    Powers, Benjamin D.
    Hodul, Pamela J.
    Malafa, Mokenge P.
    Fleming, Jason B.
    HPB, 2020, 22 (02) : 241 - 248
  • [27] Phase II Study of Adjuvant Chemotherapy With Gemcitabine and Nafamostat Mesilate for Pancreatic Cancer
    Uwagawa, Tadashi
    Sakamoto, Taro
    Yasuda, Jungo
    Shiozaki, Hironori
    Furukawa, Kenei
    Onda, Shinji
    Gocho, Takeshi
    Shiba, Hiroaki
    Yanaga, Katsuhiko
    PANCREAS, 2021, 50 (03) : 313 - 316
  • [28] A phase II study of erlotinib in patients (pts) with advanced pancreatic cancer (APC) who are refractory to gemcitabine (G)
    Iyer, R.
    Khushalani, N.
    Tan, W.
    Litwin, A.
    LeVea, C.
    Hutson, A.
    Tucker, C.
    Ma, W.
    Fakih, M.
    Adjei, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 391 - 391
  • [29] Updated results of a phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer
    Han, B.
    Kim, H. S.
    Choi, D. R.
    Shim, B. Y.
    Lee, K. H.
    Kim, J. W.
    Kim, J. H.
    Kim, H. Y.
    Song, H.
    Zang, D. Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] A randomized phase II trial of adjuvant chemotherapy with uracil / tegafur (UFT) and gemcitabine (GEM) vs. gemcitabine alone in patients with resected pancreatic cancer
    Yoshitomi, H.
    Togawa, A.
    Kimura, F.
    Shimizu, H.
    Yoshidome, H.
    Miyazaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345